Meta Pixel

News and Announcements

Flamingo receives Award at MetLife Asia

  • Published May 22, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Cre8tek Limited (ASX:CR8), owner of high-tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc. (“Flamingo”), is pleased to announce that the company won a Judge Selection Award in MetLife Asia’s Start-up accelerator program.

KEY TAKEAWAYS:

  • The award means Flamingo will work with Metlife Asia to deliver a trial of the Flamingo solution in one of Metlife’s Asian businesses. The value and terms of the contract are still to be determined.
  • Flamingo was one of eight finalists in the program and one of only three prize winners following a demonstration event in Singapore on Friday 19 May 2017 where the competing businesses pitched their technology to nine senior MetLife executives.

Dr. Catriona Wallace, Cre8tek CEO and Flamingo founder, commented:

“We are delighted to win a Judge’s Selection Award and with it the opportunity to roll out a trial of our technology in Asia. The award is further validation of the Flamingo solution, and our participation in the collab program has given us valuable exposure in the Asian market and the opportunity to work with MetLifein the region.”

Request Information

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now